# Colistin Versus Colistin Combined With Cefoperazone-sulbactam for Multiresistant Acinetobactor Baumannii Ventilator-associated Pneumonia Treatment

> **NCT07671755** · NA · COMPLETED · sponsor: **Shaheed Mohtarma Benazir Bhutto Institue of Trauma** · enrollment: 80 (actual)

## Conditions studied

- Clinical Response
- Radiological Response

## Interventions

- **DRUG:** colistin plus cefoperazone-sulbactam combination group
- **DRUG:** Colistin

## Key facts

- **NCT ID:** NCT07671755
- **Lead sponsor:** Shaheed Mohtarma Benazir Bhutto Institue of Trauma
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2026-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07671755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07671755, "Colistin Versus Colistin Combined With Cefoperazone-sulbactam for Multiresistant Acinetobactor Baumannii Ventilator-associated Pneumonia Treatment". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07671755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*